Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Feb 13:11:65.
doi: 10.3389/fimmu.2020.00065. eCollection 2020.

Adaptive Immunity: New Aspects of Pathogenesis Underlying Neurodegeneration in Glaucoma and Optic Neuropathy

Affiliations
Review

Adaptive Immunity: New Aspects of Pathogenesis Underlying Neurodegeneration in Glaucoma and Optic Neuropathy

Shuhong Jiang et al. Front Immunol. .

Abstract

Glaucoma is a globally unmet medical challenge and the most prevalent neurodegenerative disease, which permanently damages the optic nerve and retinal ganglion cells (RGCs), leading to irreversible blindness. Present therapies target solely at lowering intraocular ocular pressure (IOP), a major risk factor of the disease; however, elevated IOP is neither necessary nor sufficient to cause glaucoma. Glaucomatous RGC and nerve fiber loss also occur in individuals with normal IOP. Recent studies have provided evidence indicating a link between elevated IOP and T cell-mediated autoimmune responses, particularly that are specific to heat shock proteins (HSPs), underlying the pathogenesis of neurodegeneration in glaucoma. Reactive glial responses and low-grade inflammation may initially represent an adaptive reaction of the retina to primary stress stimuli; whereas, sustained and excessive glial reactions lead to expanded immune responses, including adaptive immunity, that contribute to progressive neural damage in glaucoma. Emerging data suggest a similar mechanism in play in causing neurodegeneration of other forms of optic neuropathy, such as that resulted from acute ischemia and traumatic injuries. These studies may lead to the paradigm shift and offer a new basis for the development of novel mechanism-based diagnosis, therapy, and preventive interventions for glaucoma. As HSPs are induced under various conditions of neural stress and damage in the brain and spinal cord, these findings may have broader implications for our elucidating of the etiology of other neurodegenerative disorders in the central nervous system.

Keywords: T cells; glaucoma; glial response; heat shock proteins; neuroinflammation; optic neuropathy.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Schematic illustration of elevated IOP-induced cellular responses in the retina. (A) Residential glial cells maintain cellular homeostasis in the normal retina. (B) In the glaucomatous retina, elevated IOP upregulates heat shock proteins (HSPs), initiates both the innate and adaptive immune responses that include microglial activation and T cell infiltration. Sustained and excessive immune responses lead to RGC apoptosis and vision loss. IOP, intraocular pressure; RGC, retinal ganglion cell; NFL, retinal nerve fiber layer.

Similar articles

Cited by

References

    1. Doucette LP, Rasnitsyn A, Seifi M, Walter MA. The interactions of genes, age, and environment in glaucoma pathogenesis. Surv Ophthalmol. (2015) 60:310–26. 10.1016/j.survophthal.2015.01.004 - DOI - PubMed
    1. Adams CM, Stacy R, Rangaswamy N, Bigelow C, Grosskreutz CL, Prasanna G. Glaucoma-next generation therapeutics: impossible to possible. Pharm Res. (2019) 36:25. 10.1007/s11095-018-2557-4 - DOI - PubMed
    1. Stein-Streilein J. Immune regulation and the eye. Trends Immunol. (2008) 29:548–54. 10.1016/j.it.2008.08.002 - DOI - PubMed
    1. Streilein JW, Wilbanks GA, Cousins SW. Immunoregulatory mechanisms of the eye. J Neuroimmunol. (1992) 39:185–200. 10.1016/0165-5728(92)90253-H - DOI - PubMed
    1. Griffith TS, Brunner T, Fletcher SM, Green DR, Ferguson TA. Fas ligand-induced apoptosis as a mechanism of immune privilege. Science. (1995) 270:1189–92. 10.1126/science.270.5239.1189 - DOI - PubMed

Publication types

Substances